We are live on ! Find out more
FBIO icon

Fortress Biotech
FBIO

36 hedge funds and large institutions have $18.5M invested in Fortress Biotech in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

321% more call options, than puts

Call options by funds: $846K | Put options by funds: $201K

14% more capital invested

Capital invested by funds: $16.3M → $18.5M (+$2.22M)

8% less funds holding

Funds holding: 39 → 36 (-3)

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

38% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 13

Holders
36
Holders Change
-3
Holders Change %
-7.69%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
8
Reduced
13
Closed
10
Calls
$846K
Puts
$201K
Net Calls
+$645K
Net Calls Change
+$377K

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$1.13M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$359K
3
SIM
Spark Investment Management
New York
+$73.8K
4
BFA
BlackRock Fund Advisors
California
+$34.9K
5
Jane Street
Jane Street
New York
+$24.5K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$394K
2
Goldman Sachs
Goldman Sachs
New York
-$257K
3
Group One Trading
Group One Trading
Illinois
-$252K
4
AA
Ancora Advisors
Ohio
-$196K
5
ACM
Advent Capital Management
New York
-$187K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$28K -$2.53K -86 -10%
BA
27
BlackRock Advisors
Delaware
$17K +$13.4K +454 New
BIM
28
BlackRock Investment Management
Delaware
$12K – – –
DAM
29
Delta Asset Management
Tennessee
$12K – – –
UBS Group
30
UBS Group
Switzerland
$8K +$6.1K +207 New
HCC
31
Hirtle Callaghan & Co
Pennsylvania
$5K – – –
EWM
32
Edge Wealth Management
New York
$3K – – –
LS
33
Lupo Securities
Illinois
$1.95K +$1.56K +53 New
TRCT
34
Tower Research Capital (TRC)
New York
$1K +$471 +16 New
BRWA
35
B. Riley Wealth Advisors
Florida
$665 +$16.9K +573 +23%
Manulife (Manufacturers Life Insurance)
36
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2 – – –
Renaissance Technologies
37
Renaissance Technologies
New York
– -$394K -12,515 Closed
Group One Trading
38
Group One Trading
Illinois
– -$252K -8,546 Closed
ACM
39
Advent Capital Management
New York
– -$187K -5,951 Closed
Credit Agricole
40
Credit Agricole
France
– -$78K -2,478 Closed
LP
41
LMR Partners
United Kingdom
– -$22K -692 Closed
BGA
42
Belmont Global Advisors
Texas
– -$21K -667 Closed
Ameriprise
43
Ameriprise
Minnesota
– -$4K -140 Closed
WA
44
WFG Advisors
Texas
– -$1K -17 Closed
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
– -$183 -6 Closed
1
2

FBIO Hedge Fund Activity: Q4 2014 in Review

36 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q4 2014, worth a combined $18.5M — up 14% from $16.3M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of FBIO and 7 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 8 added.

The largest buyer was Invesco, opening a new position worth an estimated $1.13M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $394K sold.

  • 36 institutional investors held Fortress Biotech (FBIO) as of Q4 2014, down from 39 in Q3 2014.
  • Funds reported $18.5M of Fortress Biotech stock for Q4 2014, up 14% quarter-over-quarter.
  • 7 funds opened new Fortress Biotech positions in Q4 2014 and 10 closed out, a net change of -3 holders.
  • The largest Fortress Biotech buyer in Q4 2014 was Invesco, an estimated $1.13M added.
  • The largest Fortress Biotech seller in Q4 2014 was Renaissance Technologies, an estimated $394K sold.

Based on aggregated 13F filings for Q4 2014.